What is the total value of India's pharmaceutical export to Israel?

India exported pharmaceuticals worth $174.4M to Israel across 1,223 verified shipments.

Which companies in Israel import pharmaceuticals from India?

1. ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED — $155.8M. 2. ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED — $13.2M. 3. PLASMAGEN BIOSCIENCES PRIVATE LIMITED — $2.2M. 27 buyers total.

What pharmaceutical products does India export most to Israel?

1. Vaccine ($153.5M, 88.0%); 2. Famotidine ($2.8M, 1.6%); 3. Valsartan ($2.7M, 1.6%); 4. Protein ($2.3M, 1.3%); 5. Clopidogrel ($2.1M, 1.2%)

Why does Israel import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $174.4M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Israel?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Israel pharmaceutical trade?

$142.6K per consignment across 1,223 shipments.

How many Indian pharmaceutical companies export to Israel?

52 Indian companies. Largest: ABIC BIOLOGICAL LABORATORIES LTD with $128.8M.

How can I find verified Indian pharmaceutical suppliers for Israel?

TransData Nexus covers 52 active exporters with shipment history and trade values at transdatanexus.com.

Israel to India Pharmaceutical Import (2026) — $174.4M, 52 Foreign Suppliers | TransData Nexus

Q: Who are the top Indian pharmaceutical exporters to Israel?

1. ABIC BIOLOGICAL LABORATORIES LTD — $128.8M. 2. TEVA PHARMACETICAL INDUSTRIES LTD. — $7.4M. 3. ABIC BIOLOGICAL LABORATORIES LIMITED — $5.5M. Total: 52 suppliers.

Israel to India Pharmaceutical Import (2026) — $174.4M, 52 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Israel to India

#	Formulation	Value	Share
1	Vaccine	$153.5M	88.0%
2	Famotidine	$2.8M	1.6%
3	Valsartan	$2.7M	1.6%
4	Protein	$2.3M	1.3%
5	Clopidogrel	$2.1M	1.2%
6	Anastrozole	$2.0M	1.2%
7	Amlodipine	$1.8M	1.0%
8	Sunitinib	$1.4M	0.8%
9	Plasma	$1.1M	0.6%
10	Immunoglobulin	$1.1M	0.6%
11	Darunavir	$748.4K	0.4%
12	Diclofenac	$658.0K	0.4%
13	Calcium	$405.4K	0.2%
14	Losartan	$298.5K	0.2%
15	Tenofovir	$247.1K	0.1%

India imports 20+ pharmaceutical formulations from Israel with a combined trade value of $174.4M. Key products include Vaccine ($153.5M), Famotidine ($2.8M), Valsartan ($2.7M), Protein ($2.3M), Clopidogrel ($2.1M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1,223 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Israel to India Trade Routes

1Vaccine$153.5M

2Famotidine$2.8M

3Valsartan$2.7M

4Protein$2.3M

5Clopidogrel$2.1M

6Anastrozole

Top Israel Suppliers to India

1Abic Biological Laboratories Ltd

$128.8M

2Teva Pharmacetical Industries Ltd.

$7.4M

3Abic Biological Laboratories Limited

$5.5M

4Kamada Ltd

$3.7M

5Teva Operations Poland Sp.zo.o

$2.6M

Trade Statistics

Total Value$174.4M

Shipments1,223

Indian Exporters52

Israel Buyers27

Avg Shipment$143K

Products75

Other Import Origins

United States$2.7B Germany$929.2M China$767.5M Italy

Last updated: March 28, 2026

India–Israel Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Israel and India has experienced significant growth over the past decade. In 2022, the total import value from Israel to India was approximately $174.4 million USD, encompassing 1,223 shipments from 52 Israeli suppliers to 27 Indian buyers. This robust trade relationship underscores the increasing integration of Israeli pharmaceutical products into the Indian market.

A notable contributor to this growth is the substantial import of vaccines, which accounted for $153.5 million USD, representing 88.0% of the total import value. This trend highlights Israel's pivotal role in supplying essential vaccines to India, addressing both routine immunization and emergency health needs.

2Israel's Role in India's Pharma Imports

Israel holds a significant position in India's pharmaceutical import landscape. In 2022, Israel was among the top suppliers of pharmaceutical products to India, with a total import value of $13.24 million USD. This positions Israel as a key partner in India's efforts to diversify its pharmaceutical sources and enhance the quality and availability of medicines.

The primary categories of pharmaceutical products imported from Israel include vaccines, which constitute the majority of imports, as well as other essential medications such as famotidine, valsartan, and clopidogrel. These products are crucial in addressing various health conditions prevalent in India, thereby strengthening the bilateral trade relationship.

Israel Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

For Israeli pharmaceutical companies aiming to export products to India, obtaining registration from the Central Drugs Standard Control Organisation (CDSCO) is mandatory. The process involves several key steps:

1. Application Submission: Companies must register on the CDSCO SUGAM portal, providing details about the applicant and the products intended for import.

2. Document Submission: Essential documents include the manufacturer's license, product information, and a certificate of pharmaceutical product (CPP) from the country of origin.

3. Evaluation: CDSCO evaluates the application to ensure compliance with Indian standards. This may involve site inspections and assessments of manufacturing practices.

4. Approval: Upon successful evaluation, CDSCO grants the necessary approvals, allowing the products to be imported and marketed in India.

The timeline for this process can vary, but it typically ranges from several months to a year, depending on the complexity of the application and the efficiency of the regulatory bodies involved.

2GMP & Manufacturing Standards

India requires that foreign manufacturing sites adhere to Good Manufacturing Practices (GMP) as outlined by the World Health Organization (WHO). Israeli pharmaceutical manufacturers must ensure their facilities comply with these standards to meet CDSCO's requirements. The CDSCO conducts inspections to verify compliance, focusing on aspects such as quality control, sanitation, and personnel training.

WHO prequalification is often a prerequisite for importing pharmaceutical products into India. This prequalification signifies that the products meet international quality standards, facilitating smoother entry into the Indian market.

3Import Documentation

Israeli pharmaceutical companies must prepare comprehensive documentation for importing products into India. Key documents include:

Import License (Form 10): Issued by CDSCO, this license authorizes the import of specific pharmaceutical products.

Registration Certificate: Confirms that the product has been approved for sale in India.

No Objection Certificate (NOC): Indicates that the product does not infringe on any existing patents or trademarks in India.

Test License: Allows for the testing of the imported product to ensure it meets Indian standards.

Customs procedures involve clearance of goods at Indian ports, which includes verification of documentation, inspection of goods, and payment of applicable duties and taxes. Ensuring compliance with these requirements is crucial for the smooth importation of pharmaceutical products.

TransData Nexus Research · Israel regulatory databasesMar 2026

Product Categories & Therapeutic Trends — India to Israel

Dominant categories, emerging opportunities, and demand drivers

1Dominant Import Categories

The pharmaceutical imports from Israel to India are predominantly centered around vaccines, which constitute the majority of the import value. This trend reflects Israel's strength in vaccine development and production, addressing various infectious diseases prevalent in India.

Other significant imports include medications such as famotidine, valsartan, and clopidogrel. These drugs are essential in managing conditions like gastric ulcers, hypertension, and cardiovascular diseases, respectively. The importation of these products indicates a demand for high-quality, specialized medications that may not be sufficiently produced domestically.

2Innovation & Specialty Imports

Israeli pharmaceutical companies are known for their innovative approaches, particularly in the development of biologics and novel drug formulations. India imports these advanced therapies to meet the needs of patients requiring specialized treatments not readily available within the country. This includes cutting-edge vaccines and targeted therapies for complex diseases.

3Import Demand Drivers

India's importation of pharmaceutical products from Israel is driven by several factors:

Patent Protection: Israel's strong intellectual property laws protect innovative products, ensuring that Indian companies can access patented drugs without infringement concerns.

Technology Gaps: Certain advanced pharmaceutical technologies and formulations are not yet developed domestically, necessitating imports from technologically advanced countries like Israel.

Quality Requirements: Israeli pharmaceutical products are recognized for their high quality and adherence to international standards, aligning with India's stringent regulatory requirements.

Disease Burden: The prevalence of specific diseases in India creates a demand for specialized treatments, which Israeli companies are equipped to supply.

TransData Nexus Research · DGFT trade data analysisMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Israel identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1,223 verified shipments from 52 Indian exporters to 27 Israel buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

52 Exporters

27 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Israel to India Pharmaceutical Import

Top Pharmaceutical Formulations — Israel to India

Top Pharmaceutical Products — Israel to India Trade Routes

Top Israel Suppliers to India

Trade Statistics

Other Import Origins

India–Israel Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Israel's Role in India's Pharma Imports

Top Indian Buyers from Israel

Product Routes

Full Dataset Access

3Recent Developments

Israel Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Israel

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Israel

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Israel Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

FAQ — India to Israel Pharmaceutical Trade